483
Dixon Investments IncDixon Investments Inc – FDA 483, Mar 22, 2019
Record Details
Dixon Investments, Inc. DBA ARI, an OTC liquid and aerosol drug manufacturer in Orchard Hill, GA, was inspected by the FDA. The inspection revealed significant deficiencies in manufacturing process validation, quality control testing, discrepancy investigations, and stability testing. Several observations were repeat findings, indicating persistent issues with GMP compliance.
- Office
- Atlanta District Office
- Person
View Company Profile
ID · a5d5d5be-99cc-4091-8d68-9db489700ed0
Other documents for Dixon Investments Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.